Achiko Logo cropped.jpg
Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COVID-19 Testing Solution
23 déc. 2021 07h30 HE | Achiko AG
2021 Was a Pivotal Year for Achiko, Marked by Seminal Developments and ApprovalsWith AptameX™, Achiko Launched an Innovative DNA Aptamer Saliva-Based Rapid Test for Covid-19 as an Affordable and...
AptameX™ :  Achiko’s DNA Aptamer-Based Covid-19 Rapid Test
Achiko AG’s Shares Begin Trading on the OTCQB Market
20 déc. 2021 07h30 HE | Achiko AG
ZURICH, Switzerland, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468; (“Achiko”, the “Company”), a global healthtech company which has...
Achiko Logo cropped.jpg
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
08 déc. 2021 07h50 HE | Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
COVID-19 test, COVID-19 rapid test, COVID rapid test
Scanwell Health Expands COVID-19 Research Study in North Carolina
07 oct. 2020 12h13 HE | Scanwell Health
LOS ANGELES, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Scanwell Health, a Los Angeles-based company offering at-home lab tests, announced today the expansion of the COVID-19 Community Research Partnership...